| Study Period | 2019 - 2030 |
| Base Year For Estimation | 2024 |
| Forecast Data Period | 2025 - 2030 |
| Market Size (2025) | USD 62.27 Million |
| Market Size (2030) | USD 70.45 Million |
| CAGR (2025 - 2030) | 2.50 % |
| Market Concentration | High |
Major Players
*Disclaimer: Major Players sorted in no particular order |
Brazil Bariatric Surgery Market Analysis
The Brazil Bariatric Surgery Market size is estimated at USD 62.27 million in 2025, and is expected to reach USD 70.45 million by 2030, at a CAGR of 2.5% during the forecast period (2025-2030).
In Brazil, rising obesity rates have led to a growing recognition of bariatric surgery as a crucial solution to address obesity and its associated health challenges. This surgical intervention not only offers significant weight loss but also improves the quality of life and mitigates the risks of obesity-related health issues, such as Type 2 Diabetes Mellitus (T2DM) and arterial hypertension.
The landscape of bariatric surgery in Brazil is evolving, influenced by factors such as healthcare accessibility, advancements in surgical techniques, and shifting patterns in patient demographics. For instance, in July 2023, the data published by the Brazilian Society of Bariatric and Metabolic Surgery (SBCBM) revealed a notable increase in bariatric surgeries performed by private health insurance plans, contrasting with a decline in surgeries conducted under the Unified Health System (SUS).
As per the above source, Brazil recorded 80,441 bariatric surgeries in 2023, with 7,570 performed by SUS, 3,830 by private health insurance, and a significant majority, 69,041, covered by other health plans. This shift indicates a growing reliance on private health insurance for bariatric procedures, driven by the lengthy approval processes and limited availability of surgeries under SUS. The overall volume of surgeries performed in 2023 reflects a modest increase of 7.6% from 2022, when 74,738 procedures were conducted, highlighting a gradual but steady growth trajectory in the market.
The rise in private health insurance surgeries can be attributed to several factors. Patients increasingly seek expedited access to surgical interventions due to the severe health risks associated with obesity. The market is also influenced by the increasing awareness and education about obesity-related health issues, encouraging more individuals to consider bariatric surgery as a viable option. Furthermore, the variety of surgical techniques available, such as the one anastomosis gastric bypass (OAGB), single anastomosis duodeno-ileal with sleeve gastrectomy (SADI-S or OADS), and sleeve gastrectomy with transit bipartition (SGTB), contribute to the growing appeal of bariatric surgery. In September 2023, a study published by Arquivos Brasileiros de Cirurgia Digestiva confirmed these techniques' effectiveness, showing satisfactory weight loss and resolution of comorbidities, thus bolstering confidence in surgical options.
Overall, the bariatric surgery market in Brazil is experiencing a transformative phase characterized by an increase in private health insurance-driven procedures and the adoption of innovative surgical techniques. The ongoing advancements in surgical techniques and increasing recognition of the benefits of bariatric surgery are anticipated to shape this market further, underscoring the necessity for continued investment in healthcare infrastructure and patient education.
Brazil Bariatric Surgery Market Trends
Closure Device is Expected to Witness a High Significant Growth in the Assisting Device Segment
The closure devices segment is poised for substantial growth as bariatric surgeries become increasingly common, mirroring broader market trends. Closure devices are pivotal in bariatric surgeries, ensuring the safe execution of these procedures. They are also vital for reconnecting tissues and closing incisions during laparoscopic surgeries, especially for obese patients.
Closure devices are essential in sealing port sites from laparoscopic procedures in bariatric surgeries. They efficiently and safely close small incisions, minimizing complications like infections or hernias. As minimally invasive techniques gain traction, the demand for these effective closure devices is projected to surge.
For instance, in April 2024, the Hospital das Clínicas at the Federal University of Pernambuco launched a bariatric surgery campaign for World Obesity Day, treating 12 patients with severe obesity. Such efforts highlight the urgency of tackling obesity and emphasize the rising volume of surgeries, boosting the demand for closure devices.
However, access to bariatric procedures is uneven across Brazil. In 2023, only 0.2% of severely obese Brazilians could undergo surgery via the Unified Health System (SUS). With just 98 facilities authorized for bariatric and metabolic surgeries among Brazil's 7,700 hospitals, service availability is challenging. Notably, four states—Amazonas, Rondônia, Roraima, and Amapá—lack these authorized services, underscoring a significant healthcare accessibility gap.
This limited access could bolster the market for closure devices as facilities aim to enhance surgical offerings and patient outcomes. As more hospitals integrate bariatric surgery programs, the demand for closure devices—crucial for successful surgeries—is set to rise.
Given the uptick in surgeries and the trend towards minimally invasive techniques, Brazil's closure devices segment in the bariatric market is poised for growth. With health campaigns like the one at Hospital das Clínicas driving surgical interventions, the demand for closure devices is expected to escalate. Thus, bridging the access gap in bariatric surgeries is paramount. Expanding surgical service availability nationwide will benefit patient outcomes and stimulate the market for essential technologies like closure devices.
Understand The Key Trends Shaping This Market
Download PDF
Implantable Devices is Expected to Dominate the Market Over the Forecast Period
Brazil is grappling with a growing obesity epidemic, prompting a surge in demand for effective interventions, particularly in the bariatric surgery market. Among the diverse treatment options, implantable devices, including gastric balloons and gastric bands, are gaining prominence due to their effectiveness and minimally invasive approach. These devices provide patients with a reliable method for weight loss and enhance their overall quality of life.
The rising acceptance of these implantable devices is bolstered by clinical evidence attesting to their effectiveness. With patients and healthcare providers leaning towards safer, less invasive alternatives, the appetite for devices like gastric balloons and bands is set to expand. This trend gains added significance in Brazil, where public health campaigns underscore the urgency of effective obesity management. In March 2023, Brazil introduced a new gastric balloon device, recently approved by the National Health Surveillance Agency (ANVISA). This cutting-edge device was designed to remain in the patient's stomach for four months and aims for a 15% body weight reduction. At a price of R$23,000 (USD 4,056.5), it stood out as a feasible non-surgical avenue for weight loss. While it began its journey in clinics, its broader rollout hints at a growing inclination towards less invasive bariatric solutions catering to a diverse audience.
The significance of gastric bands in the bariatric surgery domain cannot be understated. Insights from the 2023 Brazilian Congress of Bariatric and Metabolic Surgery shed light on the advantages of revisional surgeries. Notably, the removal of gastric bands mitigated complications like dysphagia, enhanced the patient's quality of life, and promoted additional weight loss. Such instances underscore the pivotal role of implantable devices in intricate clinical situations, cementing their value in the market.
Looking ahead, the implantable devices segment in Brazil's bariatric surgery market is set for notable expansion. Technological advancements, rising endorsement from patients and healthcare professionals, and favorable regulatory movements fuel this growth. The debut of innovative solutions, like gastric balloons, signals a broader transition towards efficient and minimally invasive weight loss methods.
Get Analysis on Important Geographic Markets
Download PDF
Brazil Bariatric Surgery Industry Overview
The Brazil bariatric surgery market is consolidated with major players such as Apollo Endosurgery Inc., Johnson and Johnson (Ethicon), Spatz FGIA Inc., B. Braun Melsungen A, and Medtronic holding a sizeable chunk of the market. The global players are expanding their presence in the country through product launches and collaborations.
Brazil Bariatric Surgery Market Leaders
-
Apollo Endosurgery Inc
-
B. Braun Melsungen AG
-
Medtronic
-
Johnson & Johnson Services, Inc. (Ethicon Inc)
-
Spatz FGIA Inc.
- *Disclaimer: Major Players sorted in no particular order
Need More Details on Market Players and Competiters?
Download PDF
Brazil Bariatric Surgery Market News
- April 2024: Dom Joaquim Hospital in Sombrio, accredited by the State Health Department (SES), performed the first-ever bariatric surgeries in the southern macro-region of Santa Catarina, leveraging the Unified Health System (SUS). These surgeries were carried out using video laparoscopy.
- July 2024: A state ordinance has designated the Bariatric Surgery Outpatient Clinic at Hospital São Roque in Faxinal do Soturno as eligible for financial resources from Assistir. The outpatient clinic is set to receive a state incentive of R$73 thousand.
Brazil Bariatric Surgery Industry Segmentation
As per the scope of the report, bariatric surgery or weight loss surgery is used as one of the significant treatment procedures for treating obesity. It is generally the last option for patients who have failed to lose weight by several other means. During this procedure, the stomach size is reduced by either removing some parts of the stomach or using a gastric band. The Brazil bariatric surgery market is segmented by device into assisting devices, implantable devices, and other devices. The assisting devices include suturing devices, closure devices, stapling devices, trocars, and other assisting devices. The report offers the value (in USD) for the above segments.
| By Device | Assisting Devices | Suturing Device |
| Closure Device | ||
| Stapling Device | ||
| Trocars | ||
| Other Assisting Devices | ||
| Implantable Devices | ||
| Other Devices |
Need A Different Region or Segment?
Customize Now
Brazil Bariatric Surgery Market Research FAQs
How big is the Brazil Bariatric Surgery Market?
The Brazil Bariatric Surgery Market size is expected to reach USD 62.27 million in 2025 and grow at a CAGR of 2.5% to reach USD 70.45 million by 2030.
What is the current Brazil Bariatric Surgery Market size?
In 2025, the Brazil Bariatric Surgery Market size is expected to reach USD 62.27 million.
Who are the key players in Brazil Bariatric Surgery Market?
Apollo Endosurgery Inc, B. Braun Melsungen AG, Medtronic, Johnson & Johnson Services, Inc. (Ethicon Inc) and Spatz FGIA Inc. are the major companies operating in the Brazil Bariatric Surgery Market.
What years does this Brazil Bariatric Surgery Market cover, and what was the market size in 2024?
In 2024, the Brazil Bariatric Surgery Market size was estimated at USD 60.71 million. The report covers the Brazil Bariatric Surgery Market historical market size for years: 2019, 2020, 2021, 2022, 2023 and 2024. The report also forecasts the Brazil Bariatric Surgery Market size for years: 2025, 2026, 2027, 2028, 2029 and 2030.
Our Best Selling Reports
Brazil Bariatric Surgery Industry Report
Statistics for the 2025 Brazil Bariatric Surgery market share, size and revenue growth rate, created by Mordor Intelligence™ Industry Reports. Brazil Bariatric Surgery analysis includes a market forecast outlook for 2025 to 2030 and historical overview. Get a sample of this industry analysis as a free report PDF download.
